SCHEMBL4049862

SCHEMBL4049862

CC(=O)NC1CCN(CCCN2C(=O)CCc3cc(F)c(F)cc32)CC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 19/20 1.00
CHRM4 P08173 3/20 0.68
CHRM5 P08912 3/20 0.68
DRD2 P14416 3/20 0.47
CHRM2 P08172 2/20 0.47
CHRM3 P20309 2/20 0.47
DRD4 P21917 2/20 0.47
DRD3 P35462 2/20 0.47
KCNH2 Q12809 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4053586 0.90 CHRM1 (1.00) CHRM1CHRM4CHRM5DRD2CHRM2
SCHEMBL4051705 0.89 CHRM1 (0.80) CHRM1CHRM4CHRM5DRD2CHRM2
SCHEMBL4053276 0.89 CHRM1 (0.80) CHRM1CHRM4CHRM5DRD2CHRM2
SCHEMBL4049585 0.88 CHRM1 (0.85) CHRM1CHRM4CHRM5DRD2CHRM2
SCHEMBL4058554 0.87 CHRM1 (0.81) CHRM1CHRM4CHRM5DRD2CHRM2
SCHEMBL4047861 0.84 CHRM1 (1.00) CHRM1CHRM4CHRM5DRD2CHRM2
SCHEMBL4049618 0.83 CHRM1 (0.76) CHRM1CHRM4CHRM5DRD2CHRM2
SCHEMBL4052173 0.81 CHRM1 (0.75) CHRM1CHRM4CHRM5DRD2CHRM2
SCHEMBL4055943 0.81 CHRM1 (1.00) CHRM1CHRM4CHRM5
SCHEMBL4235093 0.81 CHRM1 (0.68) CHRM1CHRM4CHRM5DRD2CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009106534-A1 NOVEL HETEROCYCLIC CARBOXAMIDES AS M1 AGONISTS H. LUNDBECK A/S (DK) 2009-09-03 WO claimed
WO-2009106534-A1 NOVEL HETEROCYCLIC CARBOXAMIDES AS M1 AGONISTS H. LUNDBECK A/S (DK) 2009-09-03 WO disclosed
WO-2009106534-A1 NOVEL HETEROCYCLIC CARBOXAMIDES AS M1 AGONISTS H. LUNDBECK A/S (DK) 2009-09-03 WO disclosed